The Leading Enterprise in China's High-End Ophthalmic Medical Device FieldTowardPi, which recently completed a D-round financing of 200 million RMB.
# Company Introduction
TowardPi was founded in 2017, with its core technology originating from the transformation of scientific and technological achievements at Tsinghua University and incubated by the Tsinghua Industrial Research Institute. The company is committed to advancing engineering technology and clinical discoveries in the field of ophthalmic medicine, aiming to become a supplier of high-end ophthalmic medical equipment across all product lines.
TowardPi's product line covers ophthalmic OCT (Optical Coherence Tomography), surgical microscopes, ultra-wide-field fundus cameras, and optical biometers. These products have not only achieved remarkable success in the Chinese market but have also been sold to dozens of countries worldwide. The company also has ophthalmic femtosecond laser and phaco-vitrectomy product lines under development, showcasing its strong R&D capabilities and promising market prospects.
Ophthalmology OCTTowardPi's OCT products include "Beiming Kun" and "Yaoguang Star," which provide全域扫频 capabilities of 400,000 and 100,000 respectively, establishing the "gold standard" for ophthalmic diagnosis.
Surgical Microscope: TowardPi's surgical microscope products, such as "Fuxue," are equipped with a digital navigation system, providing more efficient, safer, and more precise solutions for ophthalmic surgeries.
# Founder and Team
TowardPi was founded in 2017, with its core technology originating from the transformation of scientific and technological achievements at Tsinghua University, and incubated by the Tsinghua Industrial Research Institute. The core technical team of TowardPi consists of dozens of teachers and students from various specialties such as electronics, biomedical, and precision instruments at Tsinghua University. Relying on Tsinghua's technical platform, they have developed a series of globally leading high-end medical devices. The company currently has a staff of over 300, including more than 100 in the R&D team, with an annual R&D investment of nearly 100 million RMB.
# Financing History
Since its establishment, TowardPi has completed multiple rounds of financing, including the recent RMB 200 million Series D round. These financing activities have not only provided financial support for the company's R&D and market expansion but also reflected the capital market's high recognition of TowardPi's technology and market prospects. According to public information, TowardPi has completed multiple rounds of financing in less than seven years since its inception.
Editor-in-Chief | Zhao Qing Reviewed by | Yi He
